
Brain metastases: Why less radiation, more often, improves outcomes
Multi-fraction stereotactic radiotherapy reduces local failure and radiation necrosis in resectable brain metastases compared to single-fraction approaches.
Why are we still treating cancer prevention as adjunctive care?
Adopting a healthy lifestyle correlates with reduced risk for 13 distinct cancer types, highlighting the role of modifiable factors in oncology.
Insulin dosing apps: Are we overcomplicating type 2 diabetes care?
An insulin dosing app has received FDA clearance for adults with type 2 diabetes, aiming to streamline basal insulin titration and improve glycemic control.
Parkinson's cognitive decline: Is Juvmo the answer we overlooked?
The FDA approved Juvmo for adults with Parkinson's disease, targeting cognitive decline, a common and debilitating aspect of the condition.
Raw milk cheese: The 'natural' choice still sparking E. coli outbreaks?
A multi-state E. coli outbreak has been traced to raw milk cheese, prompting public health warnings across nine US states.
IBD: The silent years before symptoms begin
Inflammatory bowel disease may begin years before patients report symptoms, with subclinical inflammation detectable long before diagnosis.
Evolocumab: Is LDL-C reduction finally translating to lives saved?
Evolocumab, a PCSK9 inhibitor, has demonstrated a potential to reduce the risk of death in patients at high cardiovascular risk, offering a critical addition to lipid-lowering strategies.
Perimenopause: Why your diagnostic toolkit needs an upgrade
A new clinical toolkit offers structured guidance for managing perimenopause in primary care, addressing symptoms and improving diagnostic clarity.
Natural spring water: Why 'pure' can still mean peril for patients
A recent outbreak of illness among wedding guests highlights the persistent risks of untreated water sources, even those perceived as natural and safe. Public health investigations are underway to identify the specific pathogens and prevent further spread.